Elevance Health Inc
NYSE:ELV

Watchlist Manager
Elevance Health Inc Logo
Elevance Health Inc
NYSE:ELV
Watchlist
Price: 370.89 USD 1.35% Market Closed
Market Cap: 86B USD
Have any thoughts about
Elevance Health Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one ELV stock under the Base Case scenario is 869.86 USD. Compared to the current market price of 370.89 USD, Elevance Health Inc is Undervalued by 57%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ELV Relative Value
Base Case
869.86 USD
Undervaluation 57%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
96
vs Industry
74
Median 3Y
0.7
Median 5Y
0.7
Industry
2.3
Forward
0.5
More Details
13.4
P/E
P/E
Price to Earnings
13.4
vs History
88
vs Industry
31
Median 3Y
18.5
Median 5Y
17.7
Industry
23.1
Forward
11.1
More Details
2
P/B
P/B
Price to Book Value
2
vs History
92
vs Industry
31
Median 3Y
3
Median 5Y
2.7
Industry
2.2
More Details
0.5
Price/Premiums
Price/Premiums
Price to Premiums
0.5
vs History
96
vs Industry
40
Median 3Y
0.7
Median 5Y
0.7
Industry
0.6
More Details

Multiples Across Competitors

ELV Competitors Multiples
Elevance Health Inc Competitors

All Multiples
P/S
P/E
P/B
All Countries
All Countries
Close
Market Cap P/S P/E P/B
US
Elevance Health Inc
NYSE:ELV
86B USD 0.5 13.4 2
US
UnitedHealth Group Inc
NYSE:UNH
467.6B USD 1.2 32.7 4.7
US
Anthem Inc
LSE:0HG8
95.9B USD 0.6 14.9 2.2
US
Centene Corp
NYSE:CNC
30.7B USD 0.2 10 1.1
US
Humana Inc
NYSE:HUM
30.8B USD 0.3 22.7 1.8
US
Molina Healthcare Inc
NYSE:MOH
16.8B USD 0.4 14.7 3.5
US
Healthequity Inc
NASDAQ:HQY
8.3B USD 7.2 85.4 3.9
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
17.1B BRL 1 -40 0.3
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 7.6 1.2
US
Clover Health Investments Corp
NASDAQ:CLOV
1.6B USD 1.1 -17.8 4.8
US
Progyny Inc
NASDAQ:PGNY
1.3B USD 1.1 22.4 2.9
P/E Multiple
Earnings Growth P/E to Growth
US
Elevance Health Inc
NYSE:ELV
Average P/E: 24.8
13.4
60%
0.2
US
UnitedHealth Group Inc
NYSE:UNH
32.7
40%
0.8
US
A
Anthem Inc
LSE:0HG8
14.9
60%
0.2
US
Centene Corp
NYSE:CNC
10
51%
0.2
US
Humana Inc
NYSE:HUM
22.7
-31%
N/A
US
Molina Healthcare Inc
NYSE:MOH
14.7
56%
0.3
US
Healthequity Inc
NASDAQ:HQY
85.4
615%
0.1
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -40 N/A N/A
US
M
Magellan Health Inc
F:MAH1
7.6
N/A N/A
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.8 N/A N/A
US
Progyny Inc
NASDAQ:PGNY
22.4
25%
0.9

See Also

Summary
ELV intrinsic value, competitors valuation, and company profile.
DCF Valuation
ELV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ELV stock valuation using valuation multiples.
Wall Street Estimates
ELV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ELV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.